• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪IgG1 Fc的表面展示通过促进病毒补体逃逸和哺乳动物细胞转导提高杆状病毒载体疫苗的效力。

Surface displaying of swine IgG1 Fc enhances baculovirus-vectored vaccine efficacy by facilitating viral complement escape and mammalian cell transduction.

作者信息

Liu Zehui, Liu Yangkun, Zhang Yuanyuan, Yang Yajuan, Ren Jingjing, Zhang Xiaoying, Du Enqi

机构信息

College of Veterinary Medicine, Northwest A&F University, Yangling, Shaanxi, 712100, People's Republic of China.

出版信息

Vet Res. 2017 May 12;48(1):29. doi: 10.1186/s13567-017-0434-5.

DOI:10.1186/s13567-017-0434-5
PMID:28499403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5429525/
Abstract

Baculovirus-mediated gene transfer has been developed as a vaccine design strategy against a number of diseases without apparent viral replication. However, it has been hampered by complement-dependent inactivation, thus hindering the in vivo application of baculovirus. A variety of approaches have been exploited to bypass the complement system in the serum. In this study, we constructed and screened a series of baculovirus vectors displaying complement interfering factors, of which a baculovirus vector displaying swine IgG1 Fc (pFc) showed the highest complement antagonism (75.6%). Flow cytometry analysis of transduced cells demonstrated that the baculovirus display of pFc had a significant increase in transduction efficiency and transgene expression of reporter genes. On this basis, a VSV-G-pseudotyped with swine IgG1 Fc surface displayed baculovirus vector was developed to express the classical swine fever virus (CSFV) E2 gene. The translational enhancers Syn21 and P10UTR were incorporated to improve the antigen expression. The E2 gene was efficiently expressed in both insect and mammalian cells. Pigs immunized with this recombinant baculovirus developed high levels of E2-specific antibody, CSFV-specific neutralizing antibody and IFN-γ-secreting cellular immune responses. These results demonstrate that the strategy of surface-displaying swine IgG1 Fc has a great potential to improve the efficiency of baculovirus-vectored vaccine for CSFV and other swine pathogens.

摘要

杆状病毒介导的基因转移已被开发为一种针对多种疾病的疫苗设计策略,且无明显病毒复制。然而,它受到补体依赖性失活的阻碍,从而妨碍了杆状病毒在体内的应用。人们已采用多种方法来绕过血清中的补体系统。在本研究中,我们构建并筛选了一系列展示补体干扰因子的杆状病毒载体,其中展示猪IgG1 Fc的杆状病毒载体(pFc)表现出最高的补体拮抗作用(75.6%)。对转导细胞的流式细胞术分析表明,pFc的杆状病毒展示使报告基因的转导效率和转基因表达显著增加。在此基础上,开发了一种表面展示猪IgG1 Fc的VSV-G假型化杆状病毒载体,以表达经典猪瘟病毒(CSFV)E2基因。引入翻译增强子Syn21和P10UTR以提高抗原表达。E2基因在昆虫和哺乳动物细胞中均能有效表达。用这种重组杆状病毒免疫的猪产生了高水平的E2特异性抗体、CSFV特异性中和抗体和分泌IFN-γ的细胞免疫反应。这些结果表明,表面展示猪IgG1 Fc的策略在提高杆状病毒载体疫苗针对CSFV和其他猪病原体的效率方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/61d973ea13a2/13567_2017_434_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/701ba809faa9/13567_2017_434_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/a63873ab1dba/13567_2017_434_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/779b6dd669b4/13567_2017_434_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/51731b4e106b/13567_2017_434_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/92fd6907d83c/13567_2017_434_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/61d973ea13a2/13567_2017_434_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/701ba809faa9/13567_2017_434_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/a63873ab1dba/13567_2017_434_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/779b6dd669b4/13567_2017_434_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/51731b4e106b/13567_2017_434_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/92fd6907d83c/13567_2017_434_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/5429525/61d973ea13a2/13567_2017_434_Fig6_HTML.jpg

相似文献

1
Surface displaying of swine IgG1 Fc enhances baculovirus-vectored vaccine efficacy by facilitating viral complement escape and mammalian cell transduction.猪IgG1 Fc的表面展示通过促进病毒补体逃逸和哺乳动物细胞转导提高杆状病毒载体疫苗的效力。
Vet Res. 2017 May 12;48(1):29. doi: 10.1186/s13567-017-0434-5.
2
Glycoprotein E2 of classical swine fever virus expressed by baculovirus induces the protective immune responses in rabbits.杆状病毒表达的经典猪瘟病毒糖蛋白E2可诱导兔产生保护性免疫反应。
Vaccine. 2014 Nov 20;32(49):6607-13. doi: 10.1016/j.vaccine.2014.10.003.
3
A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.一种新型甲型肝炎病毒复制子载体疫苗通过腺病毒传递可诱导对古典猪瘟的无菌免疫。
Vaccine. 2011 Oct 26;29(46):8364-72. doi: 10.1016/j.vaccine.2011.08.085. Epub 2011 Sep 5.
4
Baculovirus surface display of E2 envelope glycoprotein of classical swine fever virus and immunogenicity of the displayed proteins in a mouse model.猪瘟病毒E2包膜糖蛋白的杆状病毒表面展示及展示蛋白在小鼠模型中的免疫原性
Vaccine. 2008 Oct 9;26(43):5455-60. doi: 10.1016/j.vaccine.2008.07.090. Epub 2008 Aug 15.
5
Immune responses induced by a BacMam virus expressing the E2 protein of classical swine fever virus in mice.
Immunol Lett. 2009 Aug 15;125(2):145-50. doi: 10.1016/j.imlet.2009.07.001. Epub 2009 Jul 7.
6
Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2).使用表达安全糖蛋白E2的羊口疮病毒重组体(ORFV VrV-E2)对经典猪瘟进行高效免疫启动。
Vaccine. 2007 Aug 1;25(31):5915-26. doi: 10.1016/j.vaccine.2007.05.035. Epub 2007 Jun 8.
7
Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus.表达经典猪瘟病毒 E2 蛋白的重组腺病毒的构建及效力评价。
Res Vet Sci. 2010 Feb;88(1):77-82. doi: 10.1016/j.rvsc.2009.06.005. Epub 2009 Jul 7.
8
Baculovirus surface display of E(rns) envelope glycoprotein of classical swine fever virus.猪瘟病毒E(rns)包膜糖蛋白的杆状病毒表面展示
J Virol Methods. 2008 Nov;153(2):149-55. doi: 10.1016/j.jviromet.2008.07.019. Epub 2008 Sep 5.
9
Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.γ干扰素诱导与 DNA 疫苗表达 E2 糖蛋白对家猪感染经典猪瘟病毒的保护作用相关。
Vet Microbiol. 2010 Apr 21;142(1-2):51-8. doi: 10.1016/j.vetmic.2009.09.043. Epub 2009 Sep 30.
10
Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.使用甲病毒复制子和腺病毒载体疫苗进行的初免-加强免疫接种可诱导小鼠对经典猪瘟病毒产生增强的免疫反应。
Vet Immunol Immunopathol. 2009 Oct 15;131(3-4):158-66. doi: 10.1016/j.vetimm.2009.04.003. Epub 2009 Apr 11.

引用本文的文献

1
An attenuated African swine fever virus expressing the E2 glycoprotein of classical swine fever virus protects pigs against challenge of both viruses.一种表达经典猪瘟病毒E2糖蛋白的减毒非洲猪瘟病毒可保护猪抵御这两种病毒的攻击。
Emerg Microbes Infect. 2025 Dec;14(1):2469636. doi: 10.1080/22221751.2025.2469636. Epub 2025 Mar 4.
2
EXTL3 and NPC1 are mammalian host factors for Autographa californica multiple nucleopolyhedrovirus infection.EXTL3 和 NPC1 是鳞翅目多角体病毒感染的哺乳动物宿主因子。
Nat Commun. 2024 Sep 4;15(1):7711. doi: 10.1038/s41467-024-52193-w.
3
A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens.

本文引用的文献

1
Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor.免疫球蛋白转运受体是增强免疫力及乳腺生物反应器构建的潜在靶点。
Front Immunol. 2016 Jun 10;7:214. doi: 10.3389/fimmu.2016.00214. eCollection 2016.
2
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits.针对病毒感染的初免-加强疫苗策略:作用机制与益处
Vaccine. 2016 Jan 20;34(4):413-423. doi: 10.1016/j.vaccine.2015.11.062. Epub 2015 Dec 13.
3
Enhanced production of porcine circovirus type 2 (PCV2) virus-like particles in Sf9 cells by translational enhancers.
病毒性疫苗防治猪病的理解与挑战综述
Viruses. 2024 May 24;16(6):833. doi: 10.3390/v16060833.
4
Impact of Molecular Modification on the Efficiency of Recombinant Baculovirus Vector Invasion to Mammalian Cells and Its Immunogenicity in Mice.分子修饰对重组杆状病毒载体感染哺乳动物细胞效率及其在小鼠中的免疫原性的影响。
Viruses. 2022 Jan 13;14(1):140. doi: 10.3390/v14010140.
5
Baculovirus Vectors Induce the Production of Interferons in Swine: Their Potential in the Development of Antiviral Strategies.杆状病毒载体诱导猪产生干扰素:其在抗病毒策略开发中的潜力。
Vet Sci. 2021 Nov 17;8(11):278. doi: 10.3390/vetsci8110278.
6
Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs.自组装纳米疫苗增强猪对 CSFV 的保护效力。
Front Immunol. 2021 Jul 21;12:689187. doi: 10.3389/fimmu.2021.689187. eCollection 2021.
7
Research Progress and Challenges in Vaccine Development against Classical Swine Fever Virus.疫苗开发防治经典猪瘟病毒的研究进展和挑战。
Viruses. 2021 Mar 10;13(3):445. doi: 10.3390/v13030445.
8
YY1 Activates WSSV Promoter for Enhanced Vaccine Production and Efficacy.YY1激活对虾白斑综合征病毒启动子以提高疫苗产量和效力。
Vaccines (Basel). 2020 Sep 8;8(3):510. doi: 10.3390/vaccines8030510.
通过翻译增强子提高猪圆环病毒2型(PCV2)病毒样颗粒在Sf9细胞中的产量。
Biotechnol Lett. 2015 Sep;37(9):1765-71. doi: 10.1007/s10529-015-1856-7. Epub 2015 May 21.
4
The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors.杆状病毒表达载体系统:一种用于病毒疫苗和基因治疗载体的商业制造平台。
Biotechnol J. 2015 May;10(5):702-14. doi: 10.1002/biot.201400438. Epub 2015 Mar 20.
5
Studying classical swine fever virus: making the best of a bad virus.研究古典猪瘟病毒:变害为宝。
Virus Res. 2015 Feb 2;197:35-47. doi: 10.1016/j.virusres.2014.12.006. Epub 2014 Dec 12.
6
Fc fusion as a platform technology: potential for modulating immunogenicity.Fc 融合作为一种平台技术:调节免疫原性的潜力。
Trends Biotechnol. 2015 Jan;33(1):27-34. doi: 10.1016/j.tibtech.2014.11.001. Epub 2014 Dec 6.
7
Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo.杆状病毒诱导的适应性免疫反应及其对体内后续转基因表达的影响。
J Virol. 2013 May;87(9):4965-73. doi: 10.1128/JVI.03510-12. Epub 2013 Feb 13.
8
Comprehensive evaluation of the adenovirus/alphavirus-replicon chimeric vector-based vaccine rAdV-SFV-E2 against classical swine fever.基于腺病毒/甲病毒复制子嵌合载体的疫苗 rAdV-SFV-E2 对古典猪瘟的综合评估。
Vaccine. 2013 Jan 7;31(3):538-44. doi: 10.1016/j.vaccine.2012.11.013. Epub 2012 Nov 12.
9
Fc-fusion proteins: new developments and future perspectives.Fc 融合蛋白:新进展与未来展望。
EMBO Mol Med. 2012 Oct;4(10):1015-28. doi: 10.1002/emmm.201201379. Epub 2012 Jul 26.
10
Polymeric human Fc-fusion proteins with modified effector functions.具有修饰效应功能的聚合物人 Fc 融合蛋白。
Sci Rep. 2011;1:124. doi: 10.1038/srep00124. Epub 2011 Oct 19.